Genetics of Complex Respiratory Diseases: Implications for Pathophysiology and Pharmacology Studies
Overview
Authors
Affiliations
There has been a huge influx of data on the genetics and genomics of respiratory diseases in the last few years. Powered by large sample sizes from collaborations worldwide, recent genome-wide association studies have convincingly implicated variants in different regions in the genome for association with complex respiratory traits. These new associations have the potential to offer invaluable insight into the pathophysiology of the normal and diseased respiratory system. The functional mechanisms underlying effects of both identified and novel variants will be the focus of research over the next few years. The identification of these mechanisms will not only increase our understanding of disease but may allow the development of new therapies to alleviate respiratory conditions. The implications of these approaches for studies of asthma and Chronic Obstructive Pulmonary Disease are covered in this review.
Precision medicine for respiratory diseases: A current viewpoint.
Georgakopoulou V, Lempesis I, Sklapani P, Trakas N, Spandidos D Med Int (Lond). 2024; 4(4):31.
PMID: 38680944 PMC: 11046260. DOI: 10.3892/mi.2024.155.
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis.
Guillen-Guio B, Paynton M, Allen R, Chin D, Donoghue L, Stockwell A ERJ Open Res. 2024; 10(1).
PMID: 38375425 PMC: 10875457. DOI: 10.1183/23120541.00553-2023.
Paternoster L, Tilling K, Davey Smith G PLoS Genet. 2017; 13(10):e1006944.
PMID: 28981501 PMC: 5628782. DOI: 10.1371/journal.pgen.1006944.
Sinha S, Singh J, Jindal S Allergy Rhinol (Providence). 2015; 6(3):168-76.
PMID: 26686208 PMC: 5391485. DOI: 10.2500/ar.2015.6.0137.
Novel cAMP signalling paradigms: therapeutic implications for airway disease.
Billington C, Hall I Br J Pharmacol. 2011; 166(2):401-10.
PMID: 22013890 PMC: 3417475. DOI: 10.1111/j.1476-5381.2011.01719.x.